ProQR to Participate in Upcoming Investor Conferences in October 2025 Oct 13, 2025 08:30AM
ProQR Therapeutics N.V. (PRQR) PT Raised to $2.50 at Chardan Capital Markets Mar 14, 2024 05:02AM
Chardan Capital Markets Upgrades ProQR Therapeutics N.V. (PRQR) to Buy Nov 8, 2023 03:48AM
ProQR Announces Third Quarter 2023 Operating and Financial Results Nov 7, 2023 07:00AM
ProQR Announces Participation in the Chardan 7th Annual Genetic Medicines Conference Sep 28, 2023 08:00AM


Apr 14, 2022 07:15AM ProQR Therapeutics N.V. (PRQR) PT Lowered to $2.50 at Chardan Capital Markets
Aug 9, 2021 08:15AM ProQR Therapeutics N.V. (PRQR) PT Lowered to $18 at Chardan Capital Markets
Oct 18, 2019 08:20AM ProQR Announces Closing of Underwritten Public Offering of Ordinary Shares with Full Exercise of Underwriters’ Option to Purchase Additional Shares
Oct 16, 2019 05:48AM ProQR (PRQR) Prices 9.09M Share Offering at $5.50/Sh
Oct 15, 2019 11:17PM ProQR Prices $50 Million Underwritten Public Offering of Ordinary Shares
Sep 30, 2019 07:00AM ProQR to Present at Two Investor Conferences in October
Oct 2, 2018 07:00AM ProQR to Present at the Chardan Genetic Medicines Conference
Sep 11, 2018 04:01PM ProQR Announces Closing of Underwritten Public Offering of Ordinary Shares with Full Exercise of Underwriters’ Option to Purchase Additional Shares
Sep 7, 2018 05:45AM ProQR (PRQR) Prices 5.75M Share Common Offering at $15.75/Sh
Sep 7, 2018 04:21AM ProQR Prices $90.6 Million Underwritten Public Offering of Ordinary Shares
Sep 5, 2018 02:42PM ProQR Therapeutics N.V. (PRQR) PT Raised to $21 at Chardan Capital Markets
Apr 5, 2018 06:12AM Chardan Capital Markets Starts ProQR Therapeutics N.V. (PRQR) at Buy
Oct 6, 2017 07:00AM ProQR to Present at the Chardan Inaugural Gene Therapy Conference
Jun 20, 2016 10:32AM Notable Analyst Rating Changes 6/20: (YELP) (SAVE) (SYMC) Upgraded; (EGRX) (SCTY) (ESRX) Downgraded
Jun 20, 2016 08:13AM UPDATE: Chardan Capital Markets Starts ProQR Therapeutics N.V. (PRQR) at Neutral